Persistent URL of this record https://hdl.handle.net/1887/3278609
In Collections
This item can be found in the following collections:
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity (vol 10, 1012, 2020)
- All authors
- Manna, F. la; Menna, M. de; Patel, N.; Karkampouna, S.; Filippo, M.R. de; Klima, I.; Kloen, P.; Beimers, L.; Thalmann, G.N.; Pelger, R.C.M.; Jacinto, E.; Kruithof-de Julio, M.
- Date
- 2021-02-03
- Title of host publication
- Frontiers in Oncology
- Volume
- 11